| Download the amazing global Makindo app: Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
| Name | Starting Dose | Frequency | Route |
|---|---|---|---|
| Caplacizumab | Initially 10 mg for 1 dose, given before plasma exchange, followed by (by subcutaneous injection) 10 mg once daily given after each plasma exchange during, and for 30 days after finishing, daily plasma exchange therapy, treatment may be continued after this if there is evidence of unresolved immunological disease. | After each plasma exchange | Route |